Where does John Glasspool work?

John Glasspool is Venture Partner at Agent Capital and Chief Executive Officer at VarmX.

What check size does John Glasspool write?

John Glasspool typically writes checks of $250K – $15M.

Where did John Glasspool go to school?

John Glasspool studied at Oxford Brookes University (Diploma in Business Administration); Tufts Center for the Study of Drug Development (Postgraduate Course in Clinical Pharmacology, Development & Regulation); University of Staffordshire (Bachelor of Arts (B.A.), Politics and International Relations).

John Glasspool

Investor

Venture Partner at Agent Capital · Chief Executive Officer at VarmX

Boston, Massachusetts

Writes $250K – $15M checks · typically $7.5M

Find your path to John

711 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

Teresa ChanunlockedJohn: together at Johnson and Johnson (2002)

×6John: together at Massachusetts Institute of Technology- NEWDIGS

×2John: together at Johnson and Johnson

John: together at University of Staffordshire

About

Venture Partner with over 25 years of commercial biopharma experience. He previously served as EVP and Head of Corporate Strategy & Commercial Operations at Baxalta and held leadership roles at Baxter, Novartis and Johnson & Johnson.

Chief Executive Officer at VarmX

Intro paths

→

In turn, John can intro founders to VarmX's investors below.

VarmX's investors · 10

BGVSilicon Valley BioGeneration VenturesNaarden EICOrinda EQT Life SciencesLuxembourg · $11M – $66M checks · since 2023 InkefAmsterdam · since 2023 Lundbeckfonden VenturesCopenhagen Sound BioventuresMalmö · since 2023 SynconaLondon · since 2020 UNIIQThe Hague Ysios CapitalBarcelona · $5.4M – $21.6M checks · since 2023

Co-founders at VarmX

Pieter Reitsma

Experience

VarmXChief Executive Officercurrent2024 — presentBoston, Massachusetts, United States and Leiden Netherlands
AronoraIndependent Board Directorcurrent2026 — present
Biotechnology Innovation OrganizationMember of the Board Emerging Companies Section Governing Boardcurrent2022 — presentWashington, United States
Agent CapitalVenture Partnercurrent2018 — presentWaltham, Massachusetts, United States
Relmada Therapeutics, IncBoard Membercurrent2019 — presentNew York, New York, United States
Massachusetts Institute of Technology- NEWDIGSSenior Advisorcurrent2016 — presentCambridge, Massachusetts, United States
Anthos Therapeutics IncCEO and President2019 — 2024Cambridge, MA, USA
DalCor PharmaceuticalsBoard Member2017 — 2023Montreal, Quebec, Canada
Roivant SciencesConsultant2017 — 2018
BaxaltaEVP, Head of Corporate Strategy and Customer Operations2015 — 2017
Baxter International Inc.VP, Head of Emerging Therapies and Market Development, Bioscience2012 — 2015
NovartisHead Region Europe - Vaccines & Diagnostic2009 — 2012Switzerland
NovartisGlobal Head Pharma Commercial Operations, Pricing and Market Access2008 — 2009
NovartisHead of Cardiovascular & Metabolism Franchise2004 — 2008
NovartisHead of Neuroscience Franchise2003 — 2004
NovartisHead of Marketing NS2002 — 2003
NovartisHead of Marketing Neurology2002 — 2003
Johnson and JohnsonDirector Strategic Marketing1991 — 2002
ScotiaSales Representative1990 — 1991

Skills & more

Market Access99Pharmaceutical Industry99Clinical Development18Pharmaceutical Sales76Oncology38Cross-functional Team Leadership39Marketing Strategy21Diabetes13Sales Effectiveness61Medical Affairs15Competitive Intelligence16Clinical Trials18

+12 more

Product LaunchCardiologyGastroenterologyNeurologyHematologyCommercializationVaccinesHypertensionHospital SalesMentoringLeadershipMarket Analysis

ABPI Pharmaceutical Examination

From John's professional profile.

Colleagues at Agent Capital

Alex Creasey

Partner & Co-Founder at Snowpoint

Andrea Heslin Smiley

Director at atai Life Sciences

Anthony DiNatale

Vice President at Agent Capital

Bob Hombach

Industry Advisor at Agent Capital

Bob Parkinson

Industry Advisor at Agent Capital

Bruce Peacock

Operating Partner at Agent Capital

Farah Champsi

Venture Advisor at Agent Capital

Geeta Vemuri

Managing Partner, Founder at Agent Capital

Network1

Geeta Vemuri

Managing Partner, Founder at Agent Capital

Investors connected to John in public investor directories — a warm-intro map.

Frequently asked questions

Who is John Glasspool?: Venture Partner with over 25 years of commercial biopharma experience. He previously served as EVP and Head of Corporate Strategy & Commercial Operations at Baxalta and held leadership roles at Baxter, Novartis and Johnson & Johnson.
Where does John Glasspool work?: John Glasspool is Venture Partner at Agent Capital and Chief Executive Officer at VarmX.
What check size does John Glasspool write?: John Glasspool typically writes checks of $250K – $15M.
Where did John Glasspool go to school?: John Glasspool studied at Oxford Brookes University (Diploma in Business Administration); Tufts Center for the Study of Drug Development (Postgraduate Course in Clinical Pharmacology, Development & Regulation); University of Staffordshire (Bachelor of Arts (B.A.), Politics and International Relations).

Founder mafias

Oxford Brookes University mafia27

Also came through, then founded or led a company.

Jeremy HindleGDipFounded Custodian +2 Henrik LangelandPsychologyFounded Enode +1 Daniel Pitchford2:1Founded Founders Forum Guy Willner1986Founded IXAfrica Matthew FrohnBachelor’s DegreeFounded Longwall Ventures Farhan QureshiBachelor of Science (B.Sc.)Founded Kuzana

+ 20 more

University of Staffordshire mafia13

Also came through, then founded or led a company.

Laduram VishnoiBachelor’s DegreeFounded Acquire +2 Russell SmithBachelor's degreeFounded 9 Mothers +1 Ng Yi YingBachelor (Hons)Founded Allsome +1 Franck NouyrigatComputer Science and NetworksFounded Massive +1 Gilles PoupardinBachelor of Arts (B.A.)Founded Whyd Sam LownBScFounded Invopop

+ 6 more

Agent Capital mafia4

Also came through, then founded or led a company.

Jacopo LeonardiAdvisorFounded 4D Path +1 Geeta VemuriManaging PartnerFounded Agent Capital Preston NoonGeneral PartnerFounded Agent Capital

Same school

Also attended Oxford Brookes University112

Matt HarrisonGeneral Counsel at Episode1 Cordelia RoydsInvestor Relations Manager at Pembroke VCT Jonathan DjanoglyIndependent Non-Executive Chairman at Pembroke VCT Riz IsmailFinance Director at InMotion Ventures Kar Hoe LumDirector, Finance at Vickers Venture Partners Henry BrodieOperating Partner & COO at 1kx

+ 106 more

Also attended University of Staffordshire36

Abdul GueforManaging Director at Intel Capital Daniel WallmanGeneral Partner at Balerion Space Ventures Najam KidwaiVenture Partner at Frontier Ventures Ginnelle LimSenior Associate at Serendipity Capital Julien FoubertInvestor at Rcube Asset Management Chris YeowartOperating Partner at DSW Ventures

+ 30 more

Shared employers

Also worked at Aronora2

Erik I. TuckerPresident & Chief Executive Officer at Aronorabio Grace ColonExecutive Officer, Director at InCarda Therapeutics

Also worked at Biotechnology Innovation Organization33

Nessan BerminghamInvestor at Khosla Ventures Tara SullivanPrincipal at Flare Capital Partners Jessica SagersCommunications Inquiries Contact at Deerfield Management Company John MaraganoreAdvisor at Oak HC/FT Thomas NagyOperational Partner at Astanor Ventures Mike DialGeneral Partner at Hatteras Venture Partners

+ 27 more

Also worked at Massachusetts Institute of Technology- NEWDIGS866

Aileen LeeFounder & Managing Partner of Cowboy Ventures Matt HuangCo-founder and Managing Partner at Paradigm Michael TruellCo-founder & CEO of Cursor Raquel UrtasunFounder & CEO of Waabi Colin WebbFounder & CEO of Avatar Robotics Abraham BachrachCo-founder & CTO of Skydio

+ 860 more

Also worked at DalCor Pharmaceuticals2

Laurence RulleauManaging Partner at CTI Life Sciences Fund L.P.Michael DixonChief Financial Officer at DalCor www.dalcorpharma.com